HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shasha He Selected Research

qiang-xin1

1/2020Qiang Xin 1 Formula Suppresses Excessive Pro-Inflammatory Cytokine Responses and Microglia Activation to Prevent Cognitive Impairment and Emotional Dysfunctions in Experimental Sepsis.
1/2020Uncovering the Molecular Mechanism of the Qiang-Xin 1 Formula on Sepsis-Induced Cardiac Dysfunction Based on Systems Pharmacology.
1/2018Qiang-Xin 1 Formula Prevents Sepsis-Induced Apoptosis in Murine Cardiomyocytes by Suppressing Endoplasmic Reticulum- and Mitochondria-Associated Pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shasha He Research Topics

Disease

36Neoplasms (Cancer)
11/2022 - 01/2014
7Neoplasm Metastasis (Metastasis)
01/2022 - 01/2018
7Inflammation (Inflammations)
01/2022 - 01/2015
6Sepsis (Septicemia)
01/2022 - 01/2015
3Hyperthermia
01/2022 - 09/2014
3Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2021 - 01/2021
2Virus Diseases (Viral Diseases)
11/2021 - 01/2020
2Ovarian Neoplasms (Ovarian Cancer)
10/2021 - 01/2020
2Thrombosis (Thrombus)
12/2020 - 01/2015
2Cognitive Dysfunction
01/2020 - 01/2020
2Breast Neoplasms (Breast Cancer)
01/2020 - 01/2018
2Osteosarcoma (Osteogenic Sarcoma)
01/2020 - 01/2017
2Hepatocellular Carcinoma (Hepatoma)
08/2019 - 01/2018
2Nasopharyngeal Carcinoma
05/2019 - 01/2019
1Hypoxia (Hypoxemia)
01/2022
1Colitis
01/2022
1Ulcerative Colitis
01/2022
1Insulin Resistance
01/2022
1Peritonitis
01/2022
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022
1Testicular Neoplasms (Testicular Cancer)
10/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Mitochondrial Diseases (Mitochondrial Disease)
01/2021
1Carcinoma (Carcinomatosis)
01/2021
1Anemia
01/2021
1Neutropenia
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
12/2020
1Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2020
1Hemorrhage
12/2020
1Endometrial Neoplasms (Endometrial Cancer)
11/2020
1Urinary Bladder Neoplasms (Bladder Cancer)
10/2020

Drug/Important Bio-Agent (IBA)

12Pharmaceutical PreparationsIBA
01/2022 - 01/2015
10PolymersIBA
11/2022 - 01/2015
7Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2017
7Cisplatin (Platino)FDA LinkGeneric
10/2021 - 01/2015
4Proteins (Proteins, Gene)FDA Link
09/2017 - 01/2014
3ProdrugsIBA
02/2022 - 01/2020
3IronIBA
01/2022 - 04/2016
3Singlet OxygenIBA
01/2022 - 01/2021
3Therapeutic UsesIBA
01/2022 - 09/2014
3PlatinumIBA
10/2021 - 01/2020
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 01/2015
3qiang-xin1IBA
01/2020 - 01/2018
3CytokinesIBA
01/2020 - 01/2019
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 04/2014
2Proteolysis Targeting ChimeraIBA
01/2022 - 01/2021
21-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2022 - 06/2020
2Small Interfering RNA (siRNA)IBA
10/2021 - 11/2020
2AntigensIBA
10/2021 - 01/2019
2Peptides (Polypeptides)IBA
01/2021 - 01/2020
2CalciumIBA
01/2021 - 01/2020
2Long Noncoding RNAIBA
01/2021 - 10/2020
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
12/2020 - 01/2020
2Ethylene Glycol (Monoethylene Glycol)IBA
01/2020 - 01/2020
2MicroRNAs (MicroRNA)IBA
01/2020 - 01/2018
2Dextrans (Dextran)FDA Link
01/2020 - 11/2015
2GTP Phosphohydrolases (GTPases)IBA
01/2018 - 09/2017
2MicellesIBA
01/2018 - 01/2015
2Monomeric GTP-Binding ProteinsIBA
01/2018 - 09/2017
1Single-Domain AntibodiesIBA
07/2022
1Immunologic Factors (Immunomodulators)IBA
02/2022
1Dietary Advanced Glycation End ProductsIBA
01/2022
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2022
1cif nucleoside transporterIBA
01/2022
1Blood Glucose (Blood Sugar)IBA
01/2022
1Butyrates (Butyrate)IBA
01/2022
1Emodin (Archin)IBA
01/2022
1Insulin (Novolin)FDA Link
01/2022
1Leukocyte Elastase (Neutrophil Elastase)IBA
01/2022
1UbiquitinIBA
01/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2022
1squamous cell carcinoma-related antigenIBA
11/2021
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
10/2021
1LipofectamineIBA
10/2021
1CRISPR-Associated Protein 9IBA
10/2021
1EnzymesIBA
01/2021
1Coloring Agents (Dyes)IBA
01/2021
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
01/2021
1LipidsIBA
01/2021
1CaspasesIBA
01/2021
1snake venom protein C activatorIBA
01/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021
1TransferasesIBA
01/2021
1Tumor Biomarkers (Tumor Markers)IBA
01/2021
1Cathepsin BIBA
01/2021
1nedaplatinIBA
01/2021
1IonsIBA
01/2021
1Heparin (Liquaemin)FDA LinkGeneric
12/2020
1Phosphotransferases (Kinase)IBA
11/2020

Therapy/Procedure

20Therapeutics
11/2022 - 01/2014
13Immunotherapy
11/2022 - 01/2019
4Lasers (Laser)
01/2022 - 01/2018
4Drug Therapy (Chemotherapy)
01/2021 - 01/2015
2Punctures
01/2021 - 01/2020
2Chemoradiotherapy
01/2021 - 05/2019
2Phototherapy (Light Therapy)
01/2021 - 01/2019
2Ligation
01/2021 - 01/2020
2Radiotherapy
01/2021 - 01/2021
2Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020 - 01/2018